Molecular Signals Involved in Ocular Neovascularization
Molecular Signals Involved in Ocular Neovascularization
批准号:
6721137
负责人:
Peter A Campochiaro
金额:
$28.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-01 至 2005-12-31
关键词:
Adenoviridaeangiogenesisangiopoietinsbiological signal transductioncapillary bedgene expressiongenetic promoter elementgenetically modified animalshypoxia inducible factor 1insulinlike growth factorischemialaboratory mousemodel design /developmentpathologic processretina circulationretina disorderretinal ganglionretinal pigment epitheliumtetracyclinestranscription factortransfection /expression vectorvascular endothelial growth factorsvisual photoreceptorvitreous body
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (From the Applicant's Abstract): The plan of this proposal is to
study interactions between factors that have been implicated in ocular
neovascularization-vascular endothelial growth factor (VEGF), hypoxia-inducible
factor-1 (HIF-1), angiopoietin 2 (Ang2), and insulin-like growth factor
(IGF-1). The plan is to use both transgenic and gene transfer approaches to
test the following hypotheses: 1) Increased expression of VEGF in the inner
retina will result in retinal neovascularization from the deep capillary bed
but not the superficial capillaries as occurs in ischemic retinopathies. 2)
Increased expression of HIF-1alpha will more closely mimic ishemic retinopathy
because it upregulates other factors in addition to VEGF. 3) Increased
production of IGF-1 in the inner retina will not be sufficient to produce
retinal neovascularization, but will enhance the effects of VEGF. 4) Increased
expression of VEGF in retinal pigment epithelial cells (RPE) is sufficient to
cause choroidal neovascularization. 5) Increased expression of Ang2 in the
retina causes regression of neovascularization, while coexpression of Ang2 and
VEGF promotes neovascularization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
-
批准号:10333382
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2022
-
负责人:Peter A Campochiaro
-
依托单位:
NAC Attack, A Phase-3, Multicenter, Randomized, Placebo-Controlled Trial in Patents with Retinitis Pigmentosa
-
批准号:10593947
-
项目类别:
-
资助金额:$42.8万
-
财政年份:2022
-
负责人:Peter A Campochiaro
-
依托单位:
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
-
批准号:10557124
-
项目类别:
-
资助金额:$59.89万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
A novel hypotonic gelling eye drop for topical treatment of retinal degenerative diseases
-
批准号:10549354
-
项目类别:
-
资助金额:$40.94万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
A novel hypotonic gelling eye drop for topical treatment of retinal degenerative diseases
-
批准号:10326840
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
Suprachoroidal nonviral gene transfer of engineered VEGF antagonists
-
批准号:10093050
-
项目类别:
-
资助金额:$58.1万
-
财政年份:2020
-
负责人:Peter A Campochiaro
-
依托单位:
Integrin-binding Peptide for Ocular Neovascularization and Macular Edema: Molecular Mechanism of Action
-
批准号:10361561
-
项目类别:
-
资助金额:$39.71万
-
财政年份:2019
-
负责人:Peter A Campochiaro
-
依托单位:
Sustained Suprachoroidal Delivery of Therapeutic Peptidesfor Ocular Diseases
-
批准号:9317491
-
项目类别:
-
资助金额:$20.44万
-
财政年份:2016
-
负责人:Peter A Campochiaro
-
依托单位:
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye
-
批准号:8964295
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2015
-
负责人:Peter A Campochiaro
-
依托单位:
Biomaterial Inhibitor of HIF-1 for Prolonged Anti-Angiogenesis in Eye
-
批准号:9256464
-
项目类别:
-
资助金额:$42.25万
-
财政年份:2015
-
负责人:Peter A Campochiaro
-
依托单位:
Novel Biodegradable Injectable Rod for Improved AMD Therapy
-
批准号:8647445
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2014
-
负责人:Peter A Campochiaro
-
依托单位:
RETINAL NEOVASCULARIZATION IN DIABETIC RETINOPATHY
-
批准号:6342681
-
项目类别:
-
资助金额:$27.44万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
RETINAL NEOVASCULARIZATION IN DIABETIC RETINOPATHY
-
批准号:2761264
-
项目类别:
-
资助金额:$27.38万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Molecular Signals Involved in Ocular Neovascularization
-
批准号:6622273
-
项目类别:
-
资助金额:$28.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Targeting survival factors for ocular neovascularization
-
批准号:7211882
-
项目类别:
-
资助金额:$40.97万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Molecular Signals Involved in Ocular Neovascularization
-
批准号:6840788
-
项目类别:
-
资助金额:$28.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Targeting survival factors for ocular neovascularization
-
批准号:7587922
-
项目类别:
-
资助金额:$39.4万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
New Treatments of Ocular Neovascularization and Macular Edema
-
批准号:8441484
-
项目类别:
-
资助金额:$38.48万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Molecular Signals Involved in Ocular Neovascularization
-
批准号:6444529
-
项目类别:
-
资助金额:$28.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
Targeting survival factors for ocular neovascularization
-
批准号:7415013
-
项目类别:
-
资助金额:$38.61万
-
财政年份:1999
-
负责人:Peter A Campochiaro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: